Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.
Smithsonian Magazine on MSN
Intermittent fasting might not live up to the hype when it comes to weight loss, new research suggests
Intermittent fasting has become a popular timed eating strategy that some researchers say has numerous health benefits. But when it comes to losing weight, the diet might not live up to the hype. An ...
Scientists raced to make drugs that help people lose as much weight as possible. Now they’re pumping the brakes.
A decade-long commitment to medically supervised care, advanced wellness therapies, and personalized health solutions ...
Researchers report that intermittent fasting is no more effective for weight loss than other dietary routines. Experts say ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label for weight loss, despite side effects like nausea, diarrhea, and abdominal ...
A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.
PHILADELPHIA -- At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a program offering surgical interventions to treat obesity. One in three ...
With insurance plans dropping coverage of the drugs, those of us benefiting from them face a costly decision — beyond just the monetary.
John Flanagan, PhD, presented new research at WVC 2026 that shows that a purpose-formulated, low-digestible carbohydrate diet combined with structured caloric restriction substantially increases short ...
Weight Loss Buddy highlights vital link between healthy weight and heart disease prevention — and how community ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results